Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapy

A multicenter, open-label, phase 2 study evaluated the efficacy and safety of intravenous vinflunine as third-line treatment in patients with progressing metastatic breast cancer (MBC) after failure of anthracycline- and taxane-based chemotherapy. Fifty-six patients with MBC, relapsing after receivi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of clinical oncology 2009-08, Vol.32 (4), p.375-380
Hauptverfasser:	Fumoleau, Pierre, Cortés-Funes, Hernan, Taleb, Amina B, Chan, Stephen, Campone, Mario, Pouget, Jean-Christophe, Tubiana-Hulin, Michèle, Slabber, Conrad F, Caroff-Paraïso, Isabelle, Alberts, Albert S, Ben Ayed, Farhat
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anthracyclines - administration & dosage Antineoplastic Agents - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Brain Neoplasms - drug therapy Brain Neoplasms - pathology Brain Neoplasms - secondary Breast Neoplasms - drug therapy Breast Neoplasms - pathology Bridged-Ring Compounds - administration & dosage Female Humans Middle Aged Neoplasm Staging Taxoids - administration & dosage Treatment Failure Vinblastine - administration & dosage Vinblastine - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!